Are Things Looking Up For Thermo Fisher Scientific Inc. (NYSE: TMO)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Thermo Fisher Scientific Inc. (TMO) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$5.40, or -1.03%, to $520.29. Volume reached 107,566 shares, with price reaching a high of $520.29 and a low of $520.29. Yahoo Finance discussed the stock recently as it posted Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Stocks Info

The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $520.29 and fluctuated between $526.96 as its day high and $518.57 as its day low. The current market capitalization of Thermo Fisher Scientific Inc. is $207.87B. A total of 1.13 million shares were traded on the day, compared to an average of 1.17M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, TMO has seen 7 BUY and 54 SELL insider trades, representing the acquisition of 74,583 and the disposition of 77,541 shares. Over the last 12 months, there were 47 BUYs and 186 SELLs from insiders. Insiders purchased 306,974 shares during that period but sold 302,287.

In the most recent transaction, Williamson Stephen sold 12,300 shares of TMO for 603.48 per share on Aug 15. After the transaction, the Sr. VP and CFO now owns 43,944 company shares. In a previous transaction on Aug 12, Williamson Stephen sold 15,000 shares at 601.32 per share. TMO shares that Sr. VP and CFO owns now total 43,944.

Among the insiders who sold shares, Boxer Michael A disposed of 7,283 shares on Aug 08 at a per-share price of $590.80. This resulted in the SVP and General Counsel holding 12,398 shares of TMO after the transaction. In another insider transaction, CASPER MARC N sold 10,000 shares at $589.76 per share on Aug 04. Company shares held by the Chairman & CEO now total 183,373.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Thermo Fisher Scientific Inc. pays an annual dividend of $1.20, resulting in a dividend yield of 0.23%, and it has a price to earnings (P/E) ratio of 27.68. TMO’s most recent ex-dividend date was 09/14/2022 when it declared a $0.30 quarterly dividend that was paid in cash on 10/14/2022. Previously, the company paid the dividend on 07/15/2022 with an ex-dividend date of 06/14/2022. The dividend was $0.30 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for TMO in the last 3 months, the mean price target is $660.15 with high estimates of $715.00 and low estimates of $525.00. In terms of 52-week highs and lows, TMO has a high of $672.34 and a low of $497.83.

As of this writing, TMO has an earnings estimate of $4.76 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of $4.9 per share and a lower estimate of $4.58. The company reported an EPS of $5.51 in the last quarter, which was 11.99% higher than expectations of $4.92.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Sell with a score of 4.36. A total of 15 analysts rated the stock as Buy while 3 rated it as Overweight while 5 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles



The 5 Best Inflation Stocks for 2022




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.